XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   145,013,786      
Beginning balance at Dec. 31, 2022 $ 339,310 $ 1 $ 951,946 $ (233) $ (612,404)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 79,922   79,922    
Exercise of stock options (in shares)   2,540,719      
Exercise of stock options 8,616   8,616    
Vesting of restricted stock units (in shares)   4,481,848      
Vesting of restricted stock units 109 $ 1 108    
Issuance of common stock under employee stock purchase plan (in shares)   625,111      
Issuance of common stock under employee stock purchase plan 4,757   4,757    
Other comprehensive income (loss) 171     171  
Net loss (87,046)       (87,046)
Ending balance (in shares) at Sep. 30, 2023   152,661,464      
Ending balance at Sep. 30, 2023 345,839 $ 2 1,045,349 (62) (699,450)
Beginning balance (in shares) at Jun. 30, 2023   149,845,546      
Beginning balance at Jun. 30, 2023 333,121 $ 1 1,015,851 (48) (682,683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 25,659   25,659    
Exercise of stock options (in shares)   1,178,316      
Exercise of stock options 3,839   3,839    
Vesting of restricted stock units (in shares)   1,637,602      
Vesting of restricted stock units 1 $ 1 0    
Other comprehensive income (loss) (14)     (14)  
Net loss (16,767)       (16,767)
Ending balance (in shares) at Sep. 30, 2023   152,661,464      
Ending balance at Sep. 30, 2023 345,839 $ 2 1,045,349 (62) (699,450)
Beginning balance (in shares) at Dec. 31, 2023   157,166,360      
Beginning balance at Dec. 31, 2023 356,892 $ 2 1,076,508 80 (719,698)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 77,164   77,164    
Exercise of stock options (in shares)   2,350,902      
Exercise of stock options 857   857    
Vesting of restricted stock units (in shares)   5,283,495      
Vesting of restricted stock units 113   113    
Issuance of common stock under employee stock purchase plan (in shares)   554,039      
Issuance of common stock under employee stock purchase plan 4,533   4,533    
Shares withheld related to net share settlement of equity awards (in shares)   (3,590,881)      
Shares withheld related to net share settlement of equity awards $ (25,465)   (25,465)    
Repurchases of common stock (in shares) (15,072,277) (15,072,277)      
Repurchases of common stock $ (142,535) $ (1) (142,534)    
Other comprehensive income (loss) 122     122  
Net loss (75,424)       (75,424)
Ending balance (in shares) at Sep. 30, 2024   146,691,638      
Ending balance at Sep. 30, 2024 196,257 $ 1 991,176 202 (795,122)
Beginning balance (in shares) at Jun. 30, 2024   151,682,337      
Beginning balance at Jun. 30, 2024 252,254 $ 2 1,022,147 (44) (769,851)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 25,531   25,531    
Exercise of stock options (in shares)   204,178      
Exercise of stock options 480   480    
Vesting of restricted stock units (in shares)   1,901,210      
Shares withheld related to net share settlement of equity awards (in shares)   (776,148)      
Shares withheld related to net share settlement of equity awards $ (5,560)   (5,560)    
Repurchases of common stock (in shares) (6,319,939) (6,319,939)      
Repurchases of common stock $ (51,423) $ (1) (51,422)    
Other comprehensive income (loss) 246     246  
Net loss (25,271)       (25,271)
Ending balance (in shares) at Sep. 30, 2024   146,691,638      
Ending balance at Sep. 30, 2024 $ 196,257 $ 1 $ 991,176 $ 202 $ (795,122)